Sensorium Therapeutics

📍 Boston, United States🗓 Founded 2021👥 24 employees💰 Last funded Nov 2022
Biotechnology Research🌐 sensorium.bio
Website LinkedIn
Founded by world-class researchers, clinicians, and thought leaders from Massachusetts General Hospital and Harvard University, Sensorium Therapeutics is a biotechnology company leveraging cutting-edge chemistry, neuroscience, and machine learning to develop nature-derived psychoactive medicines for mental health. Inspired by the real-world human benefits of plants and fungi, Sensorium’s groundbreaking Biodynamic Discovery Platform leverages cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can deliver transformational benefits to patients around the world. Visit sensorium.bio to learn more.
4
Total investors
4
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Frequently asked questions
Who invested in Sensorium Therapeutics?
Sensorium Therapeutics has 4 investors on record on gritt.io, including 4 early-stage backers.
When did Sensorium Therapeutics last raise funding?
The most recent investment in Sensorium Therapeutics recorded on gritt.io was in November 2022.
When was Sensorium Therapeutics founded?
Sensorium Therapeutics was founded in 2021.
What industry is Sensorium Therapeutics in?
Sensorium Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Sensorium Therapeutics based?
Sensorium Therapeutics is headquartered in Boston, United States.